ICU丧亲家属代理决策者延长哀伤障碍症状轨迹的相关因素
前瞻性队列研究纳入291名ICU丧亲家属代理决策者,用多项logistic回归分析三类已识别的延长哀伤障碍(PGD)症状轨迹(韧性n=242,83.2%为参照组;恢复n=35,12.0%;慢性n=14,4.8%)与风险因素的关联。代理年龄增大与恢复轨迹 membership 降低(aOR 0.918 [0.849, 0.993])、慢性轨迹升高(1.230 [1.010, 1.498])相关;丧亲后1个月焦虑症状较高与恢复(1.520 [1.256, 1.840])和慢性(2.022 [1.444, 2.831])轨迹 membership 升高相关。作者认为轨迹 membership 与ICU高质量照护可改变的因素相关,建议临床医生关注高危家属心理需求、提供高质量终末照护并转介焦虑及严重/持续PGD症状者接受心理支持。
要点
- 291名ICU丧亲代理决策者中,韧性轨迹242名(83.2%)、恢复轨迹35名(12.0%)、慢性轨迹14名(4.8%)。
- 代理年龄每增加1岁,恢复轨迹 membership 降低(aOR 0.918 [0.849, 0.993]),慢性轨迹 membership 升高(1.230 [1.010, 1.498])。
- 丧亲后1个月焦虑症状较高者,恢复轨迹 membership 升高(aOR 1.520 [1.256, 1.840]),慢性轨迹 membership 升高(2.022 [1.444, 2.831])。
- 已婚代理决策者恢复轨迹 membership 降低(aOR 0.186 [0.047, 0.729]);患者年龄增大与慢性轨迹 membership 降低相关(0.779 [0.614, 0.988])。
- 作者建议对丧亲后出现焦虑症状及严重/持续PGD症状的代理决策者及时转介心理支持,并提供高质量终末照护以促进死亡质量。
适用人群与场景
- ICU丧亲家属代理决策者,共291名;大多数为女性(59.1%)、患者成年子女(54.0%),年龄均值(标准差)49.63(12.53)岁。
研究设计与关键结果
- 前瞻性队列研究,291名ICU丧亲家属代理决策者,分析三类PGD症状轨迹(韧性n=242,83.2%为参照;恢复n=35,12.0%;慢性n=14,4.8%)与风险因素的关联。
- 代理年龄增大:恢复轨迹aOR 0.918(95%CI 0.849, 0.993),慢性轨迹aOR 1.230(95%CI 1.010, 1.498)。
- 已婚:恢复轨迹aOR 0.186(95%CI 0.047, 0.729)。
- 丧亲后1个月焦虑症状较高:恢复轨迹aOR 1.520(95%CI 1.256, 1.840),慢性轨迹aOR 2.022(95%CI 1.444, 2.831)。
- 配偶代理决策者较其他关系更可能处于两种更严重的PGD症状轨迹,成年子女代理决策者较其他关系更不可能处于这两种轨迹。
- 患者年龄增大:慢性轨迹aOR 0.779(95%CI 0.614, 0.988)。
- 与高QODD类别相比,poor-to-uncertain QODD类别与恢复轨迹 membership 接近显著的升高相关(aOR 4.342 [95%CI 0.980, 19.248])。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,轨迹 membership 与ICU高质量照护可改变的因素相关,包括丧亲早期焦虑症状和代理感知的ICU死亡质量(QODD)。
- 作者建议,临床医生应对高危家属代理决策者的心理需求保持敏感,提供高质量终末照护以促进QODD,并及时转介丧亲后出现焦虑症状和/或严重、持续PGD症状者接受心理支持。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Bereaved people experience distinct trajectories of prolonged-grief-disorder (PGD) symptoms. A few studies from outside critical care investigated limited factors of PGD-symptom trajectories without a theoretical framework. We aimed to characterize factors associated with ICU bereaved surrogates' PGD-symptom trajectories, drawing from the integrative framework of predictors for bereavement outcomes, emphasizing factors modifiable by ICU care.
METHODS: Prospective cohort study of 291 family surrogates. Multinomial logistic regression was used to determine associations of three previously identified PGD-symptom trajectories (resilient [n = 242, 83.2%] as reference group, recovery [n = 35, 12.0%], and chronic [n = 14, 4.8%]) with risk factors. Factors included intrapersonal (demographics, personal vulnerabilities), interpersonal (perceived social support), bereavement-related (patient demographics, clinical characteristics, and patient-surrogate relationship), and death-circumstance (surrogate-perceived quality of patient dying and death [QODD] in ICUs classified as high, moderate, poor-to-uncertain, and worst QODD classes) factors.
RESULTS: Most surrogates were female (59.1%), the patient's adult child (54.0%), and about (standard deviation) 49.63 (12.53) years old. As surrogate age increased, recovery-trajectory membership decreased (adjusted odds ratio [95% confidence interval] = 0.918 [0.849, 0.993]) and chronic-trajectory membership increased (1.230 [1.010, 1.498]). Being married decreased membership in the recovery (0.186 [0.047, 0.729]) trajectory. Higher anxiety symptoms 1 month post loss increased membership in recovery (1.520 [1.256, 1.840]) and chronic (2.022 [1.444, 2.831]) trajectories. Spouses were more likely and adult-child surrogates were less likely than other relationships to be in the two more profound PGD-symptom trajectories. Membership in the chronic trajectory decreased (0.779 [0.614, 0.988]) as patient age increased. The poor-to-uncertain QODD class was associated with a nearly significant increase (4.342 [0.980, 19.248]) in membership in the recovery trajectory compared to the high QODD class.
CONCLUSIONS: Membership in the PGD-symptom trajectories was associated with factors modifiable by high-quality ICU care, including anxiety symptoms at early bereavement and surrogate-perceived QODD in the ICU. Clinicians should be sensitive to the psychological needs of at-risk family surrogates, provide high-quality end-of-life care to facilitate QODD, and promptly refer bereaved surrogates who suffer anxiety symptoms and profound and/or persistent PGD-symptoms for psychological support.
参考来源
- Wen FH, Prigerson HG, Chuang LP, et al. Factors of prolonged-grief-disorder symptom trajectories for ICU bereaved family surrogates. Crit Care. 2024. PMID: 39529154. doi:10.1186/s13054-024-05160-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。